ClinicalTrials.Veeva

Menu

Seeing the World Through Assorted Glasses (SWAG)

University of North Carolina (UNC) logo

University of North Carolina (UNC)

Status

Completed

Conditions

Sleep

Treatments

Other: Placebo Lenses
Other: Amber Lenses

Study type

Interventional

Funder types

Other

Identifiers

NCT02483559
15-0389

Details and patient eligibility

About

The purpose of the study is to test the use of amber glasses at night as a method to block blue light from the eye, allowing the brain to produce a dim-light melatonin onset. The investigators hypothesize that blue-blocking will produce measurable benefits in subjectively and objectively rated sleep quality and mood as well as salivary melatonin levels during the night.

Full description

Participants will complete a self-report battery containing measures of sleep quality, morningness-eveningness chronotype, and mood. Participants will then wear a wrist-worn accelerometer for 14 days to objectively record activity level and sleep quality. Participants will also fill out a daily sleep log and short self-report measures assessing sleep and mood. On days 4-7 and 11-14 of the study the participants will wear either amber or placebo control lenses prior to sleep onset in a randomized crossover design (i.e., participants will be randomized to wear either amber lenses or placebo lenses for the first part of the protocol and then switch to wear the opposite lenses for the second part of the protocol). Participants will spend nights 7 and 14 of the study in a sleep laboratory in order to obtain hourly melatonin samples and wear a wrist sleep monitor to non-invasively and objectively measure sleep state and quality using peripheral arterial tone and oxygen perfusion.

Enrollment

15 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Good physical health
  • Proficiency in written and spoken English
  • Reported average total sleep time <9 hours (so nights spent in sleep lab will not result in sleep deprivation)

Exclusion criteria

  • Taking regular medication affecting sleep and/or mood
  • Travel across more than two time zones within the past month
  • Smoke > 5 cigarettes per day
  • Excessive caffeine use (>2 cups at one time or >500 mg daily)
  • No current Axis I Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Disorder
  • No current use of street drugs
  • No history of sleep disorder/bipolar disorder/psychosis/seizure disorder/chronic medical condition
  • Night shift work within the past 2 months

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

15 participants in 2 patient groups

Amber Lenses
Other group
Description:
Participants will be randomized to participate in the amber lens condition first or second. Outcome measures to assess the effects of wearing amber lenses to block the blue light spectrum of light includes mood and sleep rating questionnaires (Positive and Negative Affect Scale, PANAS; Leeds Sleep Evaluation Questionnaire) as well as measuring the levels of melatonin the body is producing while wearing the glasses.
Treatment:
Other: Amber Lenses
Placebo Lenses
Other group
Description:
Participants will be randomized to participate in the placebo lens condition first or second. Outcome measures to assess the effects of wearing placebo lenses to allow all spectrums of light includes mood and sleep rating questionnaires (Positive and Negative Affect Scale, PANAS; Leeds Sleep Evaluation Questionnaire) as well as measuring the levels of melatonin the body is producing while wearing the glasses.
Treatment:
Other: Placebo Lenses

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems